PTPI Petros Pharmaceuticals, Inc.
Fundamentals / CIK 0001815903 / USDPetros Pharmaceuticals, Inc. reported $3.55M in total assets and a net loss of $3.20M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open PTPI in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$3.40M Operating profit
-
Net Income FY 2025-$3.20M GAAP bottom line
-
Diluted EPS FY 2025-$0.07 Split-adjusted
-
Free Cash Flow FY 2025-- Operating CF less CapEx
-
Cash & ST Investments Jun 30, 2026$3.49M Total debt: --
Annual revenue and net income
6 fiscal years (2020 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Revenue | -- | $5.11M | $5.82M | $5.99M | $7.81M | $9.56M |
| Cost of Revenue | -- | $1.21M | $1.63M | $2.29M | $1.60M | $4.05M |
| Gross Profit | -- | $3.90M | $4.19M | $3.70M | $6.21M | $5.51M |
| Research & Development | -- | $2.62M | $2.41M | $1.74M | $1.79M | $460K |
| Selling, General & Admin | $4.64M | $4.63M | $9.26M | $12.21M | $15.59M | $15.67M |
| Total Operating Expenses | $4.64M | $4.63M | $17.81M | $23.62M | $24.26M | $22.80M |
| Operating Income | -$4.64M | -$4.63M | -$13.62M | -$19.92M | -$18.05M | -$17.28M |
| EBITDA | -- | -$1.80M | -$10.33M | -$14.32M | -$11.17M | -$10.62M |
| Interest Income | -- | $372K | $515K | $14K | -- | -- |
| Interest Expense | -- | $561K | $536K | $596K | $369K | $3.05M |
| Income Before Tax | -$4.50M | -$705K | -$8.16M | -$20.04M | -$8.99M | -$22.01M |
| Income Tax Expense | $0 | $0 | $0 | -- | $0 | -$1.43M |
| Net Income | $1.91M | -$14.32M | -$8.16M | -$20.04M | -$8.99M | -$20.59M |
| Basic EPS | -$1.56 | -$83.47 | -$158.75 | -$242.00 | -$206.25 | -$962.50 |
| Diluted EPS | -$1.56 | -$83.47 | -$158.75 | -$242.00 | -$206.25 | -$962.50 |
| Basic Shares Outstanding | 28.1M | 321.0K | 87.0K | 82.8K | 43.6K | 21.4K |
| Diluted Shares Outstanding | 28.1M | 321.0K | 87.0K | 82.8K | 43.6K | 21.4K |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | -- | $725K | $1.58M |
| Cost of Revenue | -- | -- | -- | -- | -- | -- | $265K | $287K |
| Gross Profit | -- | -- | -- | -- | -- | -- | $461K | $1.29M |
| Research & Development | -- | -- | -- | -- | -- | -- | $102K | $588K |
| Selling, General & Admin | $989K | $1.03M | $391K | $991K | $1.80M | $1.46M | $578K | $1.20M |
| Total Operating Expenses | $989K | $1.03M | $391K | $991K | $1.80M | $1.46M | $578K | $1.20M |
| Operating Income | -$989K | -$1.03M | -$391K | -$991K | -$1.80M | -$1.46M | -$578K | -$1.20M |
| EBITDA | -- | -- | -- | -- | -- | -- | $79K | -$458K |
| Interest Income | -- | -- | -- | -- | -- | -- | $25K | $76K |
| Income Before Tax | -$956K | -$987K | -$337K | -$923K | -$2.04M | -$1.20M | -$553K | -$920K |
| Net Income | -$956K | -$987K | -$337K | -$923K | $5.43M | -$2.26M | -$9.27M | -$2.22M |
| Basic EPS | -$0.30 | -$0.03 | -- | -$0.03 | -$1.20 | -$9.37 | -- | -$16.65 |
| Diluted EPS | -$0.30 | -$0.03 | -- | -$0.03 | -$1.20 | -$9.37 | -- | -$16.65 |
| Basic Shares Outstanding | 47.4M | 46.2M | -- | 42.3M | 25.9M | 1.2M | -- | 393.2K |
| Diluted Shares Outstanding | 47.4M | 46.2M | -- | 42.3M | 25.9M | 1.2M | -- | 393.2K |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $5.14M | $1.72M | $13.34M | $9.43M | $23.85M | $17.14M |
| Cash & Short-Term Investments | $5.14M | $1.72M | $13.34M | $9.43M | $23.85M | $17.14M |
| Accounts Receivable, Net | -- | $416K | $2.23M | $2.11M | $2.46M | $5.15M |
| Inventory | -- | $1.35M | $1.61M | $1.82M | $520K | $761K |
| Other Current Assets | -- | $6.5K | $111K | $138K | $110K | $115K |
| Total Current Assets | $5.16M | $7.29M | $20.39M | $14.67M | $30.54M | $25.91M |
| Property, Plant & Equipment, Net | -- | $23K | $29K | $39K | $49K | $64K |
| Intangible Assets | -- | $3.20M | $8.97M | $12.24M | $25.29M | $32.16M |
| Other Non-Current Assets | -- | -- | -- | $358K | $476K | $580K |
| Total Non-Current Assets | $0 | $3.34M | $13.41M | $17.75M | $36.85M | $43.95M |
| Total Assets | $5.16M | $10.64M | $33.80M | $32.42M | $67.39M | $69.85M |
| Accounts Payable | $84K | $764K | $1.71M | $1.81M | $4.56M | $5.61M |
| Short-Term Debt | -- | -- | -- | -- | -- | $7.18M |
| Other Current Liabilities | -- | $78K | $493K | $537K | $261K | $222K |
| Total Current Liabilities | $2.29M | $18.03M | $10.77M | $7.07M | $30.98M | $41.89M |
| Other Non-Current Liabilities | -- | $75K | $138K | $263K | $405K | $601K |
| Total Non-Current Liabilities | $0 | $75K | $10.55M | $8.65M | $865K | $10.49M |
| Total Liabilities | $2.29M | $18.10M | $21.32M | $15.72M | $31.85M | $52.38M |
| Total Debt (incl. Leases) | -- | $138K | $263K | $405K | $531K | $7.81M |
| Common Stock | $4.2K | $42 | $298 | $208 | $207 | $971 |
| Retained Earnings | -$111.3M | -$113.2M | -$98.89M | -$90.73M | -$70.69M | -$61.70M |
| Total Stockholders' Equity | $2.87M | -$7.47M | $12.07M | $16.70M | $35.54M | $17.47M |
| Total Equity | $2.87M | -$7.47M | $12.07M | $16.70M | $35.54M | $17.47M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $3.49M | $4.35M | $5.14M | $6.07M | $7.32M | $8.93M | $1.72M | $3.90M |
| Cash & Short-Term Investments | $3.49M | $4.35M | $5.14M | $6.07M | $7.32M | $8.93M | $1.72M | $3.90M |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | -- | $416K | $1.95M |
| Inventory | -- | -- | -- | -- | -- | -- | $1.35M | $1.41M |
| Other Current Assets | -- | -- | -- | -- | -- | -- | $6.5K | $4.8K |
| Total Current Assets | $3.55M | $4.39M | $5.16M | $6.13M | $7.40M | $14.47M | $7.29M | $10.72M |
| Property, Plant & Equipment, Net | -- | -- | -- | -- | -- | -- | $23K | $19K |
| Intangible Assets | -- | -- | -- | -- | -- | -- | $3.20M | $6.83M |
| Total Non-Current Assets | $0 | $0 | $0 | $0 | $0 | $3.14M | $3.34M | $9.97M |
| Total Assets | $3.55M | $4.39M | $5.16M | $6.13M | $7.40M | $17.61M | $10.64M | $20.69M |
| Accounts Payable | $97K | $133K | $84K | $421K | $970K | $757K | $764K | $1.60M |
| Other Current Liabilities | -- | -- | -- | -- | -- | -- | $78K | $353K |
| Total Current Liabilities | $2.84M | $2.62M | $2.29M | $2.77M | $2.95M | $27.13M | $18.03M | $12.56M |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | -- | $75K | $92K |
| Total Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 | $58K | $75K | $5.01M |
| Total Liabilities | $2.84M | $2.62M | $2.29M | $2.77M | $2.95M | $27.19M | $18.10M | $17.58M |
| Total Debt (incl. Leases) | -- | -- | -- | -- | -- | -- | $138K | -- |
| Common Stock | $4.2K | $4.2K | $4.2K | $4.2K | $4.2K | $205 | $42 | $1.0K |
| Retained Earnings | -$113.2M | -$112.3M | -$111.3M | -$111.0M | -$110.0M | -$115.5M | -$113.2M | -$103.9M |
| Total Stockholders' Equity | $701K | $1.77M | $2.87M | $3.37M | $4.45M | -$9.58M | -$7.47M | $3.12M |
| Total Equity | $701K | $1.77M | $2.87M | $3.37M | $4.45M | -$9.58M | -$7.47M | $3.12M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Net Income | $1.91M | -$14.32M | -$8.16M | -$20.04M | -$8.99M | -$20.59M |
| Depreciation & Amortization | -- | $2.83M | $3.28M | $5.60M | $6.88M | $6.66M |
| Stock-Based Compensation | $305K | $197K | $417K | $1.20M | $1.31M | -- |
| Change in Receivables | -- | $1.82M | -$144K | $516K | $2.55M | -$2.75M |
| Change in Inventory | -- | $308K | $274K | -$835K | $413K | $728K |
| Change in Payables | -$680K | $352K | -$93K | -$2.75M | -$1.05M | $2.22M |
| Operating Cash Flow | -$6.73M | -$2.60M | -$7.63M | -$12.80M | -$11.86M | -$15.31M |
| Capital Expenditure | -- | -$25K | -- | -- | -- | -$4.6K |
| Free Cash Flow | -- | -$2.63M | -- | -- | -- | -$15.31M |
| Investing Cash Flow | -- | -$25K | -- | -- | -- | -$4.6K |
| Common Stock Issued | $9.60M | -- | -- | -- | $21.75M | -- |
| Financing Cash Flow | $8.16M | -$7.00M | $11.54M | -$1.62M | $18.57M | $30.30M |
| Net Change in Cash | $1.43M | -$9.63M | $3.91M | -$14.42M | $6.71M | $14.99M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$956K | -$987K | -$337K | -$923K | $5.43M | -$2.26M | -$9.27M | -$2.22M |
| Depreciation & Amortization | -- | -- | -- | -- | -- | -- | $656K | $739K |
| Stock-Based Compensation | $118K | $120K | -- | -- | $74K | $80K | $0 | $0 |
| Change in Receivables | -- | -- | -- | -- | -- | -- | $1.56M | -$214K |
| Change in Inventory | -- | -- | -- | -- | -- | -- | $68K | $71K |
| Change in Payables | -$36K | $49K | -$337K | -$549K | $417K | -$212K | $420K | $144K |
| Operating Cash Flow | -$864K | -$784K | -$934K | -$1.13M | -$3.01M | -$1.66M | $965K | -$771K |
| Common Stock Issued | -- | -- | $0 | $0 | $0 | $9.60M | -- | -- |
| Financing Cash Flow | -- | -- | $0 | -$117K | -$428K | $8.71M | -$1.14M | -$2.77M |
| Net Change in Cash | -$864K | -$784K | -$934K | -$1.25M | -$3.44M | $7.05M | -$185K | -$3.57M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Gross Margin | -- | 76.3% | 72.0% | 61.8% | 79.5% | 57.7% |
| Operating Margin | -- | -90.5% | -233.9% | -332.4% | -231.1% | -180.8% |
| Net Profit Margin | -- | -280.1% | -140.2% | -334.4% | -115.0% | -215.3% |
| Return on Equity (ROE) | 66.7% | -- | -67.6% | -120.0% | -25.3% | -117.8% |
| Return on Assets (ROA) | 37.1% | -134.6% | -24.2% | -61.8% | -13.3% | -29.5% |
| Current Ratio | 2.25x | 0.40x | 1.89x | 2.08x | 0.99x | 0.62x |
| Quick Ratio | 2.24x | 0.33x | 1.74x | 1.82x | 0.97x | 0.60x |
| Debt to Equity | -- | -- | 0.02x | 0.02x | 0.01x | 0.45x |
| Revenue Growth (YoY) | -- | -12.2% | -2.8% | -23.3% | -18.3% | -- |
| Gross Profit Growth (YoY) | -- | -7.0% | +13.2% | -40.4% | +12.7% | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | -- | -- | -- | -- | -- | -- | 76.3% | 72.5% |
| Operating Margin | -- | -- | -- | -- | -- | -- | -90.5% | -225.9% |
| Net Profit Margin | -- | -- | -- | -- | -- | -- | -280.1% | -117.5% |
| Return on Equity (ROE) | -456.8% | 179.9% | 66.7% | -208.5% | -187.1% | -- | -- | -151.7% |
| Return on Assets (ROA) | -90.3% | 72.5% | 37.1% | -114.5% | -112.5% | -81.9% | -134.6% | -22.8% |
| Current Ratio | 1.25x | 1.68x | 2.25x | 2.22x | 2.51x | 0.53x | 0.40x | 0.85x |
| Quick Ratio | 1.23x | 1.66x | 2.24x | 2.20x | 2.48x | 0.33x | 0.33x | 0.74x |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -5.9% |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | +1.8% |
| Net Income Growth (YoY) | -117.6% | -- | -- | -- | -- | -- | -3014.8% | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -196.7% | -- | -- | -- | -- | -- |